91 related articles for article (PubMed ID: 5388929)
1. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). IV].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):746-55. PubMed ID: 5388929
[No Abstract] [Full Text] [Related]
2. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). 3].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):728-45. PubMed ID: 5388928
[No Abstract] [Full Text] [Related]
3. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). I].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):717-23. PubMed ID: 4900233
[No Abstract] [Full Text] [Related]
4. [Intracavitary instillation for bladder tumor with antitumor agent. 5th Report: Difference of the action of mitomycin C on normal bladder and tumor of the bladder (experimental and clinical study)].
Ogawa H; Hiraoka Y; Kawai H
Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):596-607. PubMed ID: 6413739
[No Abstract] [Full Text] [Related]
5. Intracavitary mitomycin-C in the treatment of superficial urothelial tumors: a preliminary report.
Kaufman JJ; Walther PJ; Smith RB; Skinner DG
Trans Am Assoc Genitourin Surg; 1979; 71():6-7. PubMed ID: 545816
[TBL] [Abstract][Full Text] [Related]
6. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). II].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):724-7. PubMed ID: 5388927
[No Abstract] [Full Text] [Related]
7. Plasma levels during intravesical instillation of mitomycin-C.
Kurth KH; de Wall JG; van Oosterom AT; de Jong EA; Tjaden UR
Prog Clin Biol Res; 1985; 185B():81-93. PubMed ID: 3929272
[No Abstract] [Full Text] [Related]
8. [Effects of mitomycin C perfusion after bladder tumor surgery].
Zhou CL
Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
[TBL] [Abstract][Full Text] [Related]
9. [Intravesical chemotherapy of bladder cancer using adriamycin].
Matveev BP; Shipilov VI; Romanov VA; Minakova LR; Gorilovskiĭ LM
Urol Nefrol (Mosk); 1984; (5):6-9. PubMed ID: 6506387
[No Abstract] [Full Text] [Related]
10. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
[TBL] [Abstract][Full Text] [Related]
11. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.
DeFuria MD; Bracken RB; Johnson DE; Soloway MS; Merrin CE; Morgan LR; Miller HC; Crooke ST
Cancer Treat Rep; 1980; 64(2-3):225-30. PubMed ID: 7407754
[TBL] [Abstract][Full Text] [Related]
12. Arterial infusion of 5-FU as a therapeutic adjunct in the treatment of advanced carcinoma of bladder and prostate.
Nevin JE; Melnick I; Baggerly JT; Landes R; Easley CA
Va Med Mon (1918); 1975 Aug; 102(8):614-20. PubMed ID: 1163099
[No Abstract] [Full Text] [Related]
13. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
14. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
Baker WC; Russo MA; deVere White RW
Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary fibrosis following instillation of mitomycin C in the urinary bladder].
Neubauer H; Blech M; Wilhelms E; Crieé CP; Neuhaus KL; Truss F
Urologe A; 1987 Jan; 26(1):41-3. PubMed ID: 3107190
[TBL] [Abstract][Full Text] [Related]
16. [Lung parenchyma disease following instillation of mitomycin C in the bladder].
Wilhelms E; Criée CP; Neubauer H; Neuhaus KL
Dtsch Med Wochenschr; 1986 Oct; 111(41):1564-6. PubMed ID: 3095083
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of bladder cancer: current progress.
Murphy GP
N Y State J Med; 1977 Oct; 77(12):1889-95. PubMed ID: 270015
[No Abstract] [Full Text] [Related]
18. Mitomycin C in the treatment of metastatic transitional cell carcinoma of urinary bladder.
Early K; Elias EG; Mittelman A; Albert D; Murphy GP
Cancer; 1973 May; 31(5):1150-3. PubMed ID: 4705151
[No Abstract] [Full Text] [Related]
19. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
van der Meijden AP; DeBruyne FM
Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
[TBL] [Abstract][Full Text] [Related]
20. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
Flüchter SH; Harzmann R; Erdmann D; Bichler KH
Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
